Clinical trial
Study of the Oncological Outcomes of Ileocecal Resection With D3 for Cecal Cancer
NCT06121089 is registered in ClinicalTrials.gov with Moscow Clinical Scientific Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Oncological Outcomes of Ileocecal Resection With D3 for Cecal Cancer
- Lead sponsor
- Moscow Clinical Scientific Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 1, 2022
- Completion date
- January 31, 2027
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cecal neoplasms, colonic neoplasms malignant